News & Events

Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.

Isogenica’s

Latest News

Resources

Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.

The golden age of bi-specific antibodies is here

Bi-specific antibodies (BsAbs) – antibodies that can recognise two different epitopes on either the same or different antigens – have been around for a long time. However, in the past few years we’ve seen a renaissance in the design and application of these molecules.

read more

Webinars

 

Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.

 

Isogenica’s

Newsletters

Catch up with Isogenica’s news and activies through the latest Newsletters.

🎂 Join us in celebrating our 25th birthday

🎂 Join us in celebrating our 25th birthday

Not many Biotechs get to turn 25, but this month at Isogenica we are celebrating our quarter century! This edition we look back through our 25 years of new technologies, acknowledging our wonderful partnerships….

read more
📣 Synthetic libraries are our forte and here’s why…

📣 Synthetic libraries are our forte and here’s why…

This edition we’re talking synthetic libraries: read on to see how we can save up to 8 months on immunisation alone compared with traditional approaches. Since November we’ve seen Dave attend Genesis in London, Ben go to PEGS, Barcelona, and Marion off to CAR-T, London….

read more
Creating the next generation of immunotherapies

Creating the next generation of immunotherapies

Immunotherapy has transformed the cancer treatment landscape in recent years, harnessing the power of the immune system to target cancer cells. However, checkpoint inhibitor drugs don’t work for all patients, so the hunt is on for more targeted and personalised therapies that directly engage immune cells with cancer cells.

read more

Isogenica Is Attending Bio Digital 2021

Meet David Mead, Director of Business Development and Associate Director of Marketing, Dr Mandeep Sehmi at the BIO International Convention Digital 2021 June 10-11 & 14-18, to learn the latest developments of VHH single domain antibodies to tumour targets.

read more

Stay Up to Date

Complete the below form to stay up to date with Isogenica’s latest news and events


    By signing up you accept Isogenica's Terms of Use, click here for our privacy policy. You can unsubscribe from Isogenica newsletters at any time using the links in the emails you receive. We use a third party provider, MailChimp, to deliver our newsletter.